EnWave is also active in the pharmaceutical industry. They have deals with Merck and Sutro Biopharma to develop products. The potential benefits of powderREV over freeze drying include less cost due to faster dehydration times, smaller plants needed and lower electricity and labor costs. Now this does have long sales cycles like the food business. Going through the process of the FDA or Health Canada is not fast or cheap.
The difference is this is a very high value product. You may even get higher royalties from this than weed.
As at March 6, 2018
Capital Structure
Issued and Outstanding: 100,587,759
Warrants Outstanding: 8,002,500
Broker's Warrants Outstanding: 525,539
Options Outstanding: 6,036,000
Restricted Share Units: 380,000
Fully Diluted: 115,531,798
Market Cap: $126,787,604
Q1 Revenue: $4,519,000 (2016 Q1 = $3,4676,000)
News and Company Information: ENWAVE CORPORATION
Technical Opinions: